The framework from Northwestern and UT Austin outlines the specific inpatient admission thresholds to help authorities determine when communities should enact short-term shelter-in-place orders. Powered by WPeMatico
Dr. Robert Redfield said during a House subcommittee hearing that he was only told about the decision once it had already been made by HHS. Powered by WPeMatico
To protect kids, families and staff during the pandemic, the organization expanded telemedicine offerings, supporting a 5,500% growth in virtual visits in less than a month. Powered by WPeMatico
Users working in a patient’s record can access Aunt Bertha’s network of more than 2,000 organizations. Powered by WPeMatico
Agreement with UK government aims to accelerate innovation across the public sector. Powered by WPeMatico
As part of its ongoing efforts to provide financial relief to healthcare providers impacted by the coronavirus disease 2019 (COVID-19), today the Department of Health and Human Services (HHS) is announcing an application deadline extension for the Phase 2 general distribution to Medicaid, Medicaid managed care, Children’s Health Insurance Program (CHIP) and dental providers. HHS ...
On Friday, the U.S. Court of Appeals for the D.C. Circuit ruled that the Trump Administration and HHS had the legal authority to reduce payments by 28.5 percent for drugs purchased under the 340B discount program by hospital outpatient departments, reversing a decision by the lower court on HHS’s 2017 action on this issue. HHS ...
The U.S. Department of Health and Human Services (HHS) today announced that more than 59 million COVID-19 tests have now been completed nationally – averaging over 810,000 per day over the past seven days. Over the past month, the percentage of lab tests that were completed within three days was 45; over the last seven ...
The U.S. Department of Health and Human Services (HHS) and Department of Defense (DoD) today announced agreements with Sanofi and GlaxoSmithKline (GSK) to support advanced development including clinical trials and large-scale manufacturing of 100 million doses of a COVID-19 investigational adjuvanted vaccine. By funding the manufacturing effort, the federal government will own the doses that ...
